Kabra Drugs

{
  "main_header": {
    "sid": 271637,
    "name": "Kabra Drugs",
    "stock_name": "Kabra Drugs",
    "full_name": "Kabra Drugs Ltd",
    "name_url": "stocks-analysis/kabra-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "19.65",
    "chg": -0.17,
    "chgp": "-0.86%",
    "dir": -1,
    "prev_price": "19.82",
    "mcapval": "47.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524322,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE323K01017",
    "curr_date": "Sep 01, 03:30 PM",
    "curr_time": "08:19 AM",
    "last_traded_at": "Sep 01, 03:30 PM IST",
    "bse_nse_vol": "77.52 k",
    "exc_status": "Active",
    "traded_date": "Sep 01, 2026",
    "traded_date_str": "2026 09 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kabra-drugs-271637-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kabra Drugs Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-is-rated-sell-by-marketsmojo-4159513",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KabraDrugsLtd_mojoScore_4159513.png",
        "date": "2026-08-18 10:10:39",
        "description": "Kabra Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 August 2026, providing investors with the most recent and relevant data to assess the company's outlook."
      },
      {
        "title": "Kabra Drugs Ltd Reports Outstanding Quarterly Performance Amid Shifting Financial Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kabra-drugs-ltd-reports-outstanding-quarterly-performance-amid-shifting-financial-trends-4151834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KabraDrugsLtd_fintrenddot_4151834.png",
        "date": "2026-08-13 11:00:11",
        "description": "Kabra Drugs Ltd has delivered an outstanding financial performance in the quarter ended June 2026, marking a significant improvement in its financial trend from very positive to outstanding. The pharmaceutical micro-cap company reported its highest quarterly net sales and profitability metrics in recent history, signalling a robust turnaround despite a challenging broader market environment."
      },
      {
        "title": "When is the next results date for Kabra Drugs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-kabra-drugs-ltd-4140724",
        "imagepath": "",
        "date": "2026-08-06 23:21:01",
        "description": "Kabra Drugs Ltd will declare its results on 12 August 2026...."
      },
      {
        "title": "Kabra Drugs Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-is-rated-sell-by-marketsmojo-4135160",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KabraDrugsLtd_mojoScore_4135160.png",
        "date": "2026-08-04 10:10:04",
        "description": "Kabra Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Kabra Drugs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-is-rated-sell-4115135",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KabraDrugsLtd_mojoScore_4115135.png",
        "date": "2026-07-22 10:10:32",
        "description": "Kabra Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the company’s current position as of 22 July 2026, providing investors with the latest insights into the stock’s performance and outlook."
      },
      {
        "title": "Kabra Drugs Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-is-rated-sell-by-marketsmojo-4093531",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KabraDrugsLtd_mojoScore_4093531.png",
        "date": "2026-07-08 10:10:04",
        "description": "Kabra Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 08 July 2026, providing investors with the most up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Kabra Drugs Ltd Downgraded to Sell Amid Mixed Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kabra-drugs-ltd-downgraded-to-sell-amid-mixed-financials-and-bearish-technicals-4068381",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KabraDrugsLtd_mojoScore_4068381.png",
        "date": "2026-06-23 08:32:04",
        "description": "Kabra Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 22 June 2026. This shift reflects a complex interplay of deteriorating technical indicators, valuation concerns, and mixed financial trends despite recent positive quarterly results."
      },
      {
        "title": "Kabra Drugs Gains 1.06%: 2 Key Technical Signals Shape Weekly Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kabra-drugs-gains-106-2-key-technical-signals-shape-weekly-trend-4066231",
        "imagepath": "",
        "date": "2026-06-21 11:00:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> Stock surges 13.50% to Rs.26.82 on upgrade to Hold</p>\n                    <p><strong>16 Jun:</strong> MarketsMOJO upgrades Kabra Drugs Ltd to Hold rating</p>\n                    <p><strong>17 Jun:</strong> Death Cross forms signalling potential bearish trend</p>\n                    <p><strong>19 Jun:</strong> Week closes at Rs.23.88, down 3.20% on final day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.23.63</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.23.88<..."
      },
      {
        "title": "Kabra Drugs Ltd Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kabra-drugs-ltd-forms-death-cross-signalling-potential-bearish-trend-4059719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KabraDrugsLtd_dealthcross_4059719.png",
        "date": "2026-06-17 18:00:17",
        "description": "Kabra Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock’s medium to long-term momentum and investor sentiment."
      }
    ],
    "total": 65,
    "sid": "271637",
    "stock_news_url": "https://www.marketsmojo.com/news/kabra-drugs-271637"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address",
      "datetime": "29-Aug-2026",
      "details": "Intimation regarding change in resgistered Office of the Company",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 02Nd September 2026",
      "datetime": "27-Aug-2026",
      "details": "Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve Intimation of Board Meeting to be held on 02nd September 2026",
      "source": "BSE"
    },
    {
      "caption": "Reconstitution Of The Composition Of The Board & Committees Of Regulation 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "18-Aug-2026",
      "details": "Reconstitution of the Composition of the Board & Committees of Regulation 30 of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(02 Sep 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kabra Drugs Ltd is Rated Sell by MarketsMOJO

2026-08-18 10:10:39

Kabra Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 August 2026, providing investors with the most recent and relevant data to assess the company's outlook.

Read full news article

Kabra Drugs Ltd Reports Outstanding Quarterly Performance Amid Shifting Financial Trends

2026-08-13 11:00:11

Kabra Drugs Ltd has delivered an outstanding financial performance in the quarter ended June 2026, marking a significant improvement in its financial trend from very positive to outstanding. The pharmaceutical micro-cap company reported its highest quarterly net sales and profitability metrics in recent history, signalling a robust turnaround despite a challenging broader market environment.

Read full news article

When is the next results date for Kabra Drugs Ltd?

2026-08-06 23:21:01

Kabra Drugs Ltd will declare its results on 12 August 2026....

Read full news article

Kabra Drugs Ltd is Rated Sell by MarketsMOJO

2026-08-04 10:10:04

Kabra Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Kabra Drugs Ltd is Rated Sell

2026-07-22 10:10:32

Kabra Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the company’s current position as of 22 July 2026, providing investors with the latest insights into the stock’s performance and outlook.

Read full news article

Kabra Drugs Ltd is Rated Sell by MarketsMOJO

2026-07-08 10:10:04

Kabra Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 22 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 08 July 2026, providing investors with the most up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Kabra Drugs Ltd Downgraded to Sell Amid Mixed Financials and Bearish Technicals

2026-06-23 08:32:04

Kabra Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 22 June 2026. This shift reflects a complex interplay of deteriorating technical indicators, valuation concerns, and mixed financial trends despite recent positive quarterly results.

Read full news article

Kabra Drugs Gains 1.06%: 2 Key Technical Signals Shape Weekly Trend

2026-06-21 11:00:52

Key Events This Week

15 Jun: Stock surges 13.50% to Rs.26.82 on upgrade to Hold

16 Jun: MarketsMOJO upgrades Kabra Drugs Ltd to Hold rating

17 Jun: Death Cross forms signalling potential bearish trend

19 Jun: Week closes at Rs.23.88, down 3.20% on final day

Week Open

Rs.23.63

Week Close

Rs.23.88<...

Read full news article

Kabra Drugs Ltd Forms Death Cross Signalling Potential Bearish Trend

2026-06-17 18:00:17

Kabra Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock’s medium to long-term momentum and investor sentiment.

Read full news article

View All News